Newly published data show alarmingly high rates and severity of early diabetes-specific complications in individuals who develop type 2 diabetes at a young age. This suggests intervention should be early and aggressive among these youngsters, said a researchers. The results for the 500 young adult participants in the Treatment Options for Type 2 Diabetes in […]

In type 2 diabetes (T2D), a greater degree of hyperlipidemia and hypertension, although not hyperglycemia, was associated with measurable cognitive impairment even among patients with only a 4-year mean disease duration, according to a substudy of the GRADE trial. The association of these cardiovascular (CV) risk factors with impairments in cognition has been reported before, […]

Millions of US adults aged 70 years and over previously advised to take aspirin for primary prevention would not now have it recommended for routine continued use — in particular those with diabetes at low risk of cardiovascular disease (CVD) — say the authors of a new study investigating trends in use of the medication. The […]

Two million people in England with diabetes missed out on recommended vital health checks last year during the COVID-19 pandemic, says the charity Diabetes UK, as they launch the new campaign “Diabetes Is Serious” to get the condition taken more seriously and urge the new Health Secretary to put diabetes high on the healthcare agenda. There […]

Insulet’s investigational Omnipod 5 automated insulin delivery system improves glycemic control in people with type 1 diabetes as young as 2 years of age, new data suggest. The Omnipod 5 system combines a tubing-free insulin-filled delivery “Pod” with the Dexcom G6 continuous glucose monitor and an algorithm built into the Pod connecting the two devices […]